Foamix Receives Patents for OilGel™ In the U.S. and in Australia

Cosmeticsdesign.com: Foamix granted US patent for OilGel™

LEO and Foamix to Develop Two New Medicated Foams for the Treatment of Psoriasis

Foamix Granted Third U.S. Patent for OilGel™, In Development for Dermatological and Ophthalmic Applications

Foamix Executive Director Dr. Stanley Hirsch to Present "Foamix - Innovative Delivery in Dermatology" at Bio-Europe 2005, November 8th at 8:30 a.m.

New Foam Product for the Treatment of Scabies: A Development Collaboration by Stiefel Laboratories, Inc. of the USA and Foamix Ltd. of Israel

Foamix to Showcase Emulsion-Based Cosmetic Foams at The Health and Beauty America (HBA) Conference in New York

Foamix Commences Phase II Study of TerbiFoam™ 2% Foam for the Treatment of Athlete’s Foot. Company Concurrently Conducts Phase II Study of Betamethasone 0.12% Emollient Foam for the Treatment of Psoriasis

Drug Topics: Are new lice treatments up to scratch?

Foamix lice treatment demonstrates 96% efficacy in Phase II/III study

Foamix’s PerFoam™ for the Treatment of Lice Demonstrates Safety and 96% Efficacy in Phase II/III Study

Foamix Selected to Present at the Bio Business Forum at Bio International 2005 in Philadelphia in June

ISRAEL21C: Foam - the Israeli way to take the sting out of skin treatments

in-Pharma Technologist.com: Topical Drug Delivery Gel Patented by Foamix

MarketWatch: Israel's Foamix eyes U.S. IPO in next 18 months

Globes: Drug Delivery Technology co Foamix raising $5m

Foamix Unveils Unique Mupirocin Foam

Foamix "Breaks the Ribbon" on New Facility